Literature DB >> 23277715

Association of Estrogen Receptor-α Gene & Metallothionein-1 Gene Polymorphisms in Type 2 Diabetic Women of Andhra Pradesh.

Shilpa Reddy Ganasyam1, Talluri Bhaskar Rao, Y S R Murthy, Akka Jyothy, Madireddy Sujatha.   

Abstract

Type 2 diabetes mellitus (DM) is a multifactorial disease where both genetic and environmental factors contribute to its pathogenesis. Estrogen plays an important role in type 2 DM pathogenesis. A number of polymorphisms have been reported in the estrogen receptor (ESR1), including the XbaI and PvuII restriction enzyme polymorphisms of ESR1,which may be involved in disease pathogenesis. Metallothioneins (MT) act as potent antioxidants against various oxidative damages. Very few studies have indicated the association between Estrogen Receptor-α, MT1 gene polymorphisms with type2 DM. A total of 100 type 2 diabetic women and 100 age, sex matched controls were recruited. Using the PCR based RFLP method, the PvuII and XbaI polymorphisms of ESR1 and in MT1A (rs8052394 and rs11076161) gene polymorphisms were analysed. The genotype distribution and frequency of mutated allele showed no significant differences between diabetic and non-diabetic groups in PvuII (χ2 = 2.443; P = 0.1181) or XbaI (χ2 = 1.789; P = 0.1812) and rs8052394 (χ2 = 1.154; P = 0.2840) or rs11076161 (χ2 = 0.4141; P = 0.5199), polymorphisms. This is the first Indian study to conclude that ESR1 and MT1 gene polymorphisms are not associated with increased susceptibility to type 2 diabetes in Indian women.

Entities:  

Keywords:  Estrogen receptor1 (ESR1); High density lipoprotein (HDL); Low density lipoprotein (LDL); Metallothionein (MT); Polymerase chain reaction (PCR); Restriction fragment length polymorphism (RFLP); Triglycerides (TG); Type 2 diabetes mellitus (T2DM); Very low density lipoprotein (VLDL)

Year:  2012        PMID: 23277715      PMCID: PMC3286578          DOI: 10.1007/s12291-011-0179-2

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  24 in total

1.  Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity.

Authors:  G Speer; K Cseh; G Winkler; P Vargha; E Braun; I Takács; P Lakatos
Journal:  Eur J Endocrinol       Date:  2001-04       Impact factor: 6.664

2.  Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia.

Authors:  Hong Lu; Toshinori Higashikata; Akihiro Inazu; Atsushi Nohara; Wenxin Yu; Masami Shimizu; Hiroshi Mabuchi
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-05-01       Impact factor: 8.311

3.  Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes.

Authors:  H Chen; E C Carlson; L Pellet; J T Moritz; P N Epstein
Journal:  Diabetes       Date:  2001-09       Impact factor: 9.461

4.  Obesity and hyperleptinemia in metallothionein (-I and -II) null mice.

Authors:  J H Beattie; A M Wood; A M Newman; I Bremner; K H Choo; A E Michalska; J S Duncan; P Trayhurn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

5.  Short-term oestrogen replacement therapy improves insulin resistance, lipids and fibrinolysis in postmenopausal women with NIDDM.

Authors:  H E Brussaard; J A Gevers Leuven; M Frölich; C Kluft; H M Krans
Journal:  Diabetologia       Date:  1997-07       Impact factor: 10.122

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

7.  Epidemiology of type 2 diabetes: Indian scenario.

Authors:  V Mohan; S Sandeep; R Deepa; B Shah; C Varghese
Journal:  Indian J Med Res       Date:  2007-03       Impact factor: 2.375

8.  Metallothionein gene cluster is split by chromosome 16 rearrangements in myelomonocytic leukaemia.

Authors:  M M Le Beau; M O Diaz; M Karin; J D Rowley
Journal:  Nature       Date:  1985 Feb 21-27       Impact factor: 49.962

9.  Rapid insulinotropic effect of 17beta-estradiol via a plasma membrane receptor.

Authors:  A Nadal; J M Rovira; O Laribi; T Leon-quinto; E Andreu; C Ripoll; B Soria
Journal:  FASEB J       Date:  1998-10       Impact factor: 5.191

10.  A genome-wide scan for type 2 diabetes in African-American families reveals evidence for a locus on chromosome 6q.

Authors:  Michèle M Sale; Barry I Freedman; Carl D Langefeld; Adrienne H Williams; Pamela J Hicks; Carla J Colicigno; Stephanie R Beck; W Mark Brown; Stephen S Rich; Donald W Bowden
Journal:  Diabetes       Date:  2004-03       Impact factor: 9.461

View more
  5 in total

1.  Genetic polymorphism of estrogen receptor alpha gene in Egyptian women with type II diabetes mellitus.

Authors:  Tarek M K Motawi; Mahmoud A El-Rehany; Sherine M Rizk; Maggie M Ramzy; Doaa M El-Roby
Journal:  Meta Gene       Date:  2015-09-02

2.  Association of Estrogen Receptor α Genes PvuII and XbaI Polymorphisms with Type 2 Diabetes Mellitus in the Inpatient Population of a Hospital in Southern Iran.

Authors:  Farzaneh Mohammadi; Mohammad Pourahmadi; Mohadeseh Mosalanejad; Houshang Jamali; Mohamed Amin Ghobadifar; Saeideh Erfanian
Journal:  Diabetes Metab J       Date:  2013-08-14       Impact factor: 5.376

3.  Estrogen receptor 1 gene polymorphisms (PvuII and XbaI) are associated with type 2 diabetes in Palestinian women.

Authors:  Suheir Ereqat; Stéphane Cauchi; Khaled Eweidat; Muawiyah Elqadi; Abedelmajeed Nasereddin
Journal:  PeerJ       Date:  2019-06-28       Impact factor: 2.984

4.  The genetic susceptibility profile of type 2 diabetes and reflection of its possible role related to reproductive dysfunctions in the southern Indian population of Hyderabad.

Authors:  Kumuda Irgam; Battini Sriteja Reddy; Sai Gayathri Hari; Swathi Banapuram; Battini Mohan Reddy
Journal:  BMC Med Genomics       Date:  2021-11-16       Impact factor: 3.063

5.  Metallothionein MT2A A-5G Polymorphism as a Risk Factor for Chronic Kidney Disease and Diabetes: Cross-Sectional and Cohort Studies.

Authors:  Yuta Hattori; Mariko Naito; Masahiko Satoh; Masahiro Nakatochi; Hisao Naito; Masashi Kato; Sahoko Takagi; Takashi Matsunaga; Toshio Seiki; Tae Sasakabe; Shino Suma; Sayo Kawai; Rieko Okada; Asahi Hishida; Nobuyuki Hamajima; Kenji Wakai
Journal:  Toxicol Sci       Date:  2016-04-27       Impact factor: 4.849

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.